NCT05553457 MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
| NCT ID | NCT05553457 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Spinal Cord Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2022-10-04 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2022-10-04 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to develop and test the hardware and software components of the MyHand-SCI device to assist with hand function for individuals with C6-C7 spinal cord injury.
Eligibility Criteria
Inclusion Criteria: * Individuals with C6-C7 spinal cord injury, at least 6-months post-injury with impaired upper limb function * Substantially reduced motor control and strength below the level of their SCI with regard to hand and finger function * Able to provide informed consent Exclusion Criteria: * Fixed upper limb contractures that limit functional use of the hand and arm or ability to use the device * Severe spasticity (modified Ashworth \>2) at elbow, wrist, or fingers * Any open wounds or unusual skin fragility * Persistent severe pain in their upper limb
Contact & Investigator
Joel Stein, MD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT05553457 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05553457 currently recruiting?
Yes, NCT05553457 is actively recruiting participants. Contact the research team at lbw2136@cumc.columbia.edu for enrollment information.
Where is the NCT05553457 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05553457 clinical trial?
NCT05553457 is sponsored by Columbia University. The principal investigator is Joel Stein, MD at Columbia University. The trial plans to enroll 40 participants.